gvtcx

National Microbiology Framework - Lot 2: Research and Development Goods and Services

Public Health England Published 10 May 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 33000000
Procedureopen
OCIDocds-h6vhtk-02a9d6

Awards (138)

This procurement was awarded to 79 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
Abbott Rapid Diagnostics Limited shared £1,500,000,000 12 Mar 2021 active
Abbott Rapid Diagnostics Limited shared · · active
Abcam Plc shared £1,500,000,000 12 Mar 2021 active
Abcam Plc shared · · active
Acarrier Limited shared £1,500,000,000 12 Mar 2021 active
Acarrier Limited shared · · active
Agena Bioscience GmbH shared £1,500,000,000 12 Mar 2021 active
Agena Bioscience GmbH shared · · active
A.Menarini Diagnostics Ltd shared £1,500,000,000 12 Mar 2021 active
A.Menarini Diagnostics Ltd shared · · active
Appleton Woods Ltd shared £1,500,000,000 12 Mar 2021 active
Appleton Woods Ltd shared · · active
AusDiagnostics UK Limited shared · · active
AusDiagnostics UK Ltd shared £1,500,000,000 12 Mar 2021 active
Becton, Dickinson U.K. Limited shared £1,500,000,000 12 Mar 2021 active
Becton, Dickinson U.K. Limited shared · · active
BGI Genomics UK CO LTD shared £1,500,000,000 12 Mar 2021 active
BGI Genomics UK CO LTD shared · · active
BioConnections Ltd shared £1,500,000,000 12 Mar 2021 active
BioConnections Ltd shared · · active
Bio-Rad Laboratories Limited shared £1,500,000,000 12 Mar 2021 active
Bio-Rad Laboratories Limited shared · · active
Bioserv UK shared · · active
Bioserv UK Limited shared £1,500,000,000 12 Mar 2021 active
BioSpyder Technologies, Inc. shared £1,500,000,000 12 Mar 2021 active
BioSpyder Technologies, Inc. shared · · active
Bio-Techne Ltd shared £1,500,000,000 12 Mar 2021 active
Bio-Techne Ltd shared · · active
Cambridge Bioscience Limited shared £1,500,000,000 12 Mar 2021 active
Cambridge Bioscience Limited shared · · active
Cambridge Life Sciences Limited shared £1,500,000,000 12 Mar 2021 active
Cambridge Life Sciences Limited shared · · active
Clent Life Science shared £1,500,000,000 12 Mar 2021 active
Clent Life Science shared · · active
Don Whitley Scientific Ltd shared £1,500,000,000 12 Mar 2021 active
Don Whitley Scientific Ltd shared · · active
Eurofins Biomnis UK Ltd shared £1,500,000,000 12 Mar 2021 active
Eurofins Biomnis UK Ltd shared · · active
Euroimmun UK Ltd shared £1,500,000,000 12 Mar 2021 active
Euroimmun UK Ltd shared · · active
Europlaz Technologies Limited shared · · active
Europlaz Technologies Ltd shared £1,500,000,000 12 Mar 2021 active
Fisher Scientific shared · · active
Fisher Scientific UK Limited shared £1,500,000,000 12 Mar 2021 active
Fujirebio Europe shared £1,500,000,000 12 Mar 2021 active
Fujirebio Europe shared · · active
GeneFirst Limited shared £1,500,000,000 12 Mar 2021 active
GeneFirst Limited shared · · active
Global Life Sciences Solutions Operations UK Ltd shared £1,500,000,000 12 Mar 2021 active
Global Life Sciences Solutions Operations UK Ltd shared · · active
Greiner Bio-One Ltd shared £1,500,000,000 12 Mar 2021 active
Greiner Bio-One Ltd shared · · active
Hamilton Robotics Ltd shared · · active
Hamilton Sales and Service UK Ltd shared £1,500,000,000 12 Mar 2021 active
Healthlinked Ltd shared £1,500,000,000 12 Mar 2021 active
Healthlinked Ltd shared · · active
Hologic Limited shared £1,500,000,000 12 Mar 2021 active
Hologic Limited shared · · active
Illumina Cambridge Ltd shared £1,500,000,000 12 Mar 2021 active
Illumina Cambridge Ltd shared · · active
Immensa Health Clinic Ltd shared £1,500,000,000 12 Mar 2021 active
Immensa Health Clinic Ltd shared · · active
Intertek Testing & Certification Limited shared · · active
Intertek Testing & Certification Ltd shared £1,500,000,000 12 Mar 2021 active
LGC Genomics Limited shared £1,500,000,000 12 Mar 2021 active
LGC Genomics Limited shared · · active
Life Technologies Limited shared £1,500,000,000 12 Mar 2021 active
Life Technologies Limited shared · · active
Luminex Corporation shared £1,500,000,000 12 Mar 2021 active
Luminex Corporation shared · · active
Malvern Medical Developments Ltd shared £1,500,000,000 12 Mar 2021 active
Malvern Medical Developments Ltd shared · · active
MGI International Sales Co. Ltd shared £1,500,000,000 12 Mar 2021 active
MGI International Sales Co. Ltd shared · · active
Microbial Genomics Ltd (Trading as MicrobesNG) shared £1,500,000,000 12 Mar 2021 active
Microbial Genomics Ltd (Trading as MicrobesNG) shared · · active
Mornington 2000 LLP trading as Sterilab Services shared £1,500,000,000 12 Mar 2021 active
Mornington 2000LLP trading as Sterilab Services shared · · active
Natural History Museum Trading Company Ltd shared £1,500,000,000 12 Mar 2021 active
Natural History Museum Trading Company Ltd shared · · active
New England Biolabs UK Ltd shared £1,500,000,000 12 Mar 2021 active
New England Biolabs UK Ltd shared · · active
Oxford Biosystems Ltd shared £1,500,000,000 12 Mar 2021 active
Oxford Biosystems Ltd shared · · active
Oxford Immunotec Ltd shared £1,500,000,000 12 Mar 2021 active
Oxford Immunotec Ltd shared · · active
Oxford Nanopore Diagnostics Limited shared · · active
Oxford Nanopore Diagnostics Ltd shared £1,500,000,000 12 Mar 2021 active
PCR Biosystems Ltd shared £1,500,000,000 12 Mar 2021 active
PCR Biosystems Ltd shared · · active
PerkinElmer LAS (UK) Limited shared £1,500,000,000 12 Mar 2021 active
PerkinElmer LAS (UK) Limited shared · · active
ProMake Ltd shared £1,500,000,000 12 Mar 2021 active
ProMake Ltd shared · · active
Promega UK Ltd shared £1,500,000,000 12 Mar 2021 active
Promega UK Ltd shared · · active
Qiagen Ltd shared £1,500,000,000 12 Mar 2021 active
Qiagen Ltd shared · · active
Quanterix Corporation shared £1,500,000,000 12 Mar 2021 active
Quanterix Corporation shared · · active
QuantuMDx Group Limited shared £1,500,000,000 12 Mar 2021 active
QuantuMDx Group Limited shared · · active
Randox Laboratories Ltd shared £1,500,000,000 12 Mar 2021 active
Randox Laboratories Ltd shared · · active
Roche Diagnostics Limited shared £1,500,000,000 12 Mar 2021 active
Roche Diagnostics Limited shared · · active
Sarstedt Ltd shared £1,500,000,000 12 Mar 2021 active
Sarstedt Ltd shared · · active
Scientific Laboratory Supplies Ltd shared £1,500,000,000 12 Mar 2021 active
Scientific Laboratory Supplies Ltd shared · · active
Siemens Healthcare Diagnostics Limited shared · · active
Siemens Healthcare Diagnostics Ltd shared £1,500,000,000 12 Mar 2021 active
Sterilin Ltd shared £1,500,000,000 12 Mar 2021 active
Stratech Scientific Ltd shared £1,500,000,000 12 Mar 2021 active
Stratech Scientific Ltd shared · · active
Sysmex UK Ltd shared £1,500,000,000 12 Mar 2021 active
Sysmex UK Ltd shared · · active
Tecan UK shared £1,500,000,000 12 Mar 2021 active
Tecan UK shared · · active
Techno-path Distribution Ltd shared £1,500,000,000 12 Mar 2021 active
Techno-path Distribution Ltd shared · · active
Teva UK Ltd shared £1,500,000,000 12 Mar 2021 active
Teva UK Ltd shared · · active
Thermo Electron Manufacturing Ltd T/A Thermo Fisher Scientific shared £1,500,000,000 12 Mar 2021 active
Thermo Electron Manufacturing Ltd T/A Thermo Fisher Scientific shared · · active
Thermo Fisher Diagnostics Ltd shared £1,500,000,000 12 Mar 2021 active
Thermo Fisher Diagnostics Ltd shared · · active
Thermofisher Scientific T/A Sterilin Ltd shared · · active
Una Health Ltd shared £1,500,000,000 12 Mar 2021 active
Una Health Ltd shared · · active
V. H. Bio Limited shared £1,500,000,000 12 Mar 2021 active
V. H. Bio Limited shared · · active
VWR International Ltd shared £1,500,000,000 12 Mar 2021 active
VWR International Ltd shared · · active
Wolf Laboratories Limited shared £1,500,000,000 12 Mar 2021 active
Wolf Laboratories Limited shared · · active
Yourgene Health UK Limited shared £1,500,000,000 12 Mar 2021 active
Yourgene Health UK Limited shared · · active

description

Lot 2 is for the supply of goods and/or services for the qualitative/quantitative examination of specimens/samples and the development of assays/kits/medical or therapeutic products. This Lot consists of goods and services mainly for research and development, experimentation and study therefore CE marked (or UKCA marked) is not mandatory. This Lot includes provisions for reagent rental and managed equipment services.

Please note that this Award Notice is for Lot 2, however the Framework Agreement encompasses the following four lots:

  • Lot 1: Diagnostic Goods and Services
  • Lot 2: Research and Development Goods and Services
  • Lot 3: Manufacturing, Product Development and Commercialisation
  • Lot 4: Clinical Laboratory Diagnostic Testing Services

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
23 Apr 2021 Contract award notice (F03) Earlier regulations 008805-2021
10 May 2021 Corrigendum (F14) Earlier regulations 010197-2021
10 May 2021 Award update (awardUpdate) · babba604-719a-4dcf-9225-c17719e533f9-435177

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.